Article info
Drug information (i. anti-infectives, ii. cytostatics, iii. others)
DGI-018 Budget Impact Analysis on New 3-Year Imatinib Adjuvant Treatment For Patients with Operable GIST at High Risk of Recurrence
Citation
DGI-018 Budget Impact Analysis on New 3-Year Imatinib Adjuvant Treatment For Patients with Operable GIST at High Risk of Recurrence
Publication history
- First published March 12, 2013.
Online issue publication
March 12, 2013
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2013, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions